PMID: 12694200Apr 16, 2003

Complex II from phototrophic purple bacterium Rhodoferax fermentans displays rhodoquinol-fumarate reductase activity

European Journal of Biochemistry
Hiroko MiyaderaKiyoshi Kita


It has long been accepted that bacterial quinol-fumarate reductase (QFR) generally uses a low-redox-potential naphthoquinone, menaquinone (MK), as the electron donor, whereas mitochondrial QFR from facultative and anaerobic eukaryotes uses a low-redox-potential benzoquinone, rhodoquinone (RQ), as the substrate. In the present study, we purified novel complex II from the RQ-containing phototrophic purple bacterium, Rhodoferax fermentans that exhibited high rhodoquinol-fumarate reductase activity in addition to succinate-ubiquinone reductase activity. SDS/PAGE indicated that the purified R. fermentans complex II comprises four subunits of 64.0, 28.6, 18.7 and 17.5 kDa and contains 1.3 nmol heme per mg protein. Phylogenetic analysis and comparison of the deduced amino acid sequences of R. fermentans complex II with pro/eukaryotic complex II indicate that the structure and the evolutional origins of R. fermentans complex II are closer to bacterial SQR than to mitochondrial rhodoquinol-fumarate reductase. The results strongly indicate that R. fermentans complex II and mitochondrial QFR might have evolved independently, although they both utilize RQ for fumarate reduction.


Nov 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·James RegeimbalJames C A Bardwell
Dec 24, 2011·Journal of Bacteriology·Zachary T LonjersJennifer N Shepherd
Aug 1, 2009·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Eriko TomitsukaHiroyasu Esumi
Nov 26, 2009·Journal of Bacteriology·Brian C BrajcichJennifer N Shepherd
Jan 22, 2013·Biochimica Et Biophysica Acta·Shigeharu HaradaKiyoshi Kita
Jun 1, 2016·Microbiological Research·Beatrycze Nowicka, Jerzy Kruk
May 17, 2012·Biochimica Et Biophysica Acta·Maria-Eirini PandeliaWolfgang Nitschke
Jul 6, 2010·Biochimica Et Biophysica Acta·Beatrycze Nowicka, Jerzy Kruk
Feb 20, 2018·Bioscience, Biotechnology, and Biochemistry·Makoto Kawamukai
Mar 12, 2004·The Journal of Biological Chemistry·Meike HoffmeisterWilliam Martin
Jan 11, 2020·Frontiers in Neurology·Xingao WangZaiqiang Zhang


Jan 15, 1990·Biochemical and Biophysical Research Communications·K KitaM Kasahara
Sep 14, 1988·Biochimica Et Biophysica Acta·J D PennoyerB L Trumpower
Mar 1, 1988·Molecular and Biochemical Parasitology·C F Fioravanti, Y Kim
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Grundström, B Jaurin
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Dec 29, 1995·The Journal of Biological Chemistry·J J Van HellemondA G Tielens
Nov 25, 1996·Molecular and Biochemical Parasitology·J J Van HellemondA G Tielens
Apr 11, 1997·The Journal of Biological Chemistry·X YangC A Yu
Jun 13, 1997·Biochimica Et Biophysica Acta·C Hägerhäll
Jun 1, 1997·International Journal for Parasitology·K KitaS Takamiya
Aug 7, 1998·Biochimica Et Biophysica Acta·A G Tielens, J J Van Hellemond
Jul 10, 1999·Science·L Hederstedt
Jul 27, 1999·Journal of Bacteriology·D J Westenberg, M L Guerinot

Related Concepts

Conserved Sequence
Succinate Dehydrogenase
Chromatography, DEAE-Cellulose
Fumarate Reductase Activity
Homologous Sequences, Amino Acid

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.